National Institute on Drug Abuse Notice of Closed Meetings, 1650 [2015-00282]
Download as PDF
1650
Federal Register / Vol. 80, No. 8 / Tuesday, January 13, 2015 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse
Notice of Closed Meetings
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Identification of Gene Variants for Addiction
Related Traits by Next-Gen Sequencing in
Model Organisms Selectively Bred for
Addiction Traits (UH2/UH3).
Date: January 22, 2015.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Jagadeesh S. Rao, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Boulevard, Room
4234, MSC 9550, Bethesda, MD 02892, 301–
443–9511, jrao@nida.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIDA I/
START Small Grant Review (R03).
Date: February 19, 2015.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Virtual
Meeting).
Contact Person: Minna Liang, Ph.D.,
Scientific Review Officer, Grants Review
Branch, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, 6001 Executive Blvd., Room 4226,
MSC 9550, Bethesda, MD 20892–9550, 301–
435–1432, liangm@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIH
Pathway to Independence Award (K99/R00)
Review.
Date: March 11, 2015.
VerDate Sep<11>2014
17:10 Jan 12, 2015
Jkt 235001
Time: 11:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Hiromi Ono, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Boulevard, Room
4238, MSC 9550, Bethesda, MD 20892, 301–
402–6020, hiromi.ono@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Abuse Prevention, Drug Testing
Advisory Board.
Dates/Time/Type: February 5, 2015,
from 11:00 a.m. to 5:00 p.m. E.S.T.:
CLOSED, February 6, 2015, from 9:00
a.m. to 2:00 p.m. E.S.T.: CLOSED.
Place: Sugarloaf Conference Room,
SAMHSA Building, 1 Choke Cherry
Road, Rockville, Maryland 20850.
Contact: Janine Denis Cook, Ph.D.,
Designated Federal Official, CSAP Drug
Testing Advisory Board, 1 Choke Cherry
Road, Room 7–1043, Rockville,
Maryland 20857, Telephone: 240–276–
2600, Fax: 240–276–2610, Email:
janine.cook@samhsa.hhs.gov.
Dated: January 7, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
Janine Denis Cook,
Designated Federal Official, DTAB, Division
of Workplace Programs, Center for Substance
Abuse Prevention, Substance Abuse and
Mental Health Services Administration.
[FR Doc. 2015–00282 Filed 1–12–15; 8:45 am]
[FR Doc. 2015–00310 Filed 1–12–15; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Center for Substance Abuse
Prevention; Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Prevention
(CSAP) Drug Testing Advisory Board
(DTAB) will meet on February 5, 2015,
from 11:00 a.m. to 5:00 p.m., and
February 6, 2015, from 9:00 a.m. to 2:00
p.m. E.S.T. The DTAB will convene in
closed sessions on these two days.
On February 5, 2015, from 11:00 a.m.
to 5:00 p.m., and February 6, 2015, from
9:00 a.m. to 2:00 p.m., the Board will
meet in closed session to discuss
confidential hair testing best practices
and data, as well as proposed revisions
to the Mandatory Guidelines for Federal
Workplace Drug Testing Programs.
Therefore, this meeting is closed to the
public as determined by the
Administrator, SAMHSA, in accordance
with 5 U.S.C. 552b(c)(4), 5 U.S.C.
552b(c)(9)(B), and 5 U.S.C. App. 2,
Section 10(d).
Meeting information and a roster of
DTAB members may be obtained by
accessing the SAMHSA Advisory
Committees Web site, https://www.
samhsa.gov/about-us/advisory-councils/
drug-testing-advisory-board-dtab, or by
contacting Dr. Cook.
Committee Name: Substance Abuse
and Mental Health Services
Administration’s, Center for Substance
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[1651–0121]
Agency Information Collection
Activities: Trusted Traveler Programs
and U.S. APEC Business Travel Card
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: 30-Day notice and request for
comments; extension of an existing
collection of information.
AGENCY:
U.S. Customs and Border
Protection (CBP) of the Department of
Homeland Security will be submitting
the following information collection
request to the Office of Management and
Budget (OMB) for review and approval
in accordance with the Paperwork
Reduction Act: Trusted Traveler
Programs and U.S. APEC Business
Travel Card. This is a proposed
extension of an information collection
that was previously approved. CBP is
proposing that this information
collection be extended with no change
to the burden hours or to the
information collected. This document is
published to obtain comments from the
public and affected agencies.
DATES: Written comments should be
received on or before February 12, 2015
to be assured of consideration.
ADDRESSES: Interested persons are
invited to submit written comments on
this proposed information collection to
the Office of Information and Regulatory
Affairs, Office of Management and
SUMMARY:
E:\FR\FM\13JAN1.SGM
13JAN1
Agencies
[Federal Register Volume 80, Number 8 (Tuesday, January 13, 2015)]
[Notices]
[Page 1650]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-00282]
[[Page 1650]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable materials, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Identification of Gene Variants for Addiction
Related Traits by Next-Gen Sequencing in Model Organisms Selectively
Bred for Addiction Traits (UH2/UH3).
Date: January 22, 2015.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Telephone Conference
Call).
Contact Person: Jagadeesh S. Rao, Ph.D., Scientific Review
Officer, Office of Extramural Affairs, National Institute on Drug
Abuse, National Institutes of Health, DHHS, 6001 Executive
Boulevard, Room 4234, MSC 9550, Bethesda, MD 02892, 301-443-9511,
jrao@nida.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIDA I/START Small Grant Review (R03).
Date: February 19, 2015.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Virtual Meeting).
Contact Person: Minna Liang, Ph.D., Scientific Review Officer,
Grants Review Branch, Office of Extramural Affairs, National
Institute on Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4226,
MSC 9550, Bethesda, MD 20892-9550, 301-435-1432,
liangm@nida.nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIH Pathway to Independence Award (K99/R00) Review.
Date: March 11, 2015.
Time: 11:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Telephone Conference
Call).
Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer,
Office of Extramural Affairs, National Institute on Drug Abuse,
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room
4238, MSC 9550, Bethesda, MD 20892, 301-402-6020,
hiromi.ono@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: January 7, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-00282 Filed 1-12-15; 8:45 am]
BILLING CODE 4140-01-P